Healthcare provider profile · identity verified

Lawrence Rosenbaum, M.D.

Internal Medicine · SANTA CRUZ, CA · NPI 1467555474

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	337	91
Levothyroxine Sodium	Levothyroxine Sodium	307	76
Atorvastatin Calcium	Atorvastatin Calcium	305	87
Rosuvastatin Calcium	Rosuvastatin Calcium	300	86
Amlodipine Besylate	Amlodipine Besylate	270	74
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	195	33
Metoprolol Succinate	Metoprolol Succinate	167	49
Pantoprazole Sodium	Pantoprazole Sodium	158	50
Losartan Potassium	Losartan Potassium	150	39
Gabapentin	Gabapentin	125	47
Duloxetine Hcl	Duloxetine Hcl	123	25
Tamsulosin Hcl	Tamsulosin Hcl	123	37
Eliquis	Apixaban	115	26
Trazodone Hcl	Trazodone Hcl	111	33
Montelukast Sodium	Montelukast Sodium	88	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	88	12
Albuterol Sulfate Hfa	Albuterol Sulfate	80	27
Ozempic	Semaglutide	77	suppressed
Metformin Hcl	Metformin Hcl	71	22
Zolpidem Tartrate	Zolpidem Tartrate	71	26
Omeprazole	Omeprazole	69	20
Pravastatin Sodium	Pravastatin Sodium	65	17
Diazepam	Diazepam	63	13
Allopurinol	Allopurinol	62	17
Chlorthalidone	Chlorthalidone	60	22
Torsemide	Torsemide	59	16
Finasteride	Finasteride	57	16
Ibandronate Sodium	Ibandronate Sodium	57	21
Potassium Chloride	Potassium Chloride	57	20
Donepezil Hcl	Donepezil Hcl	56	16
Farxiga	Dapagliflozin Propanediol	55	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	21
Lorazepam	Lorazepam	53	17
Nitroglycerin	Nitroglycerin	52	38
Mirtazapine	Mirtazapine	50	12
Bupropion Xl	Bupropion Hcl	49	11
Escitalopram Oxalate	Escitalopram Oxalate	48	12
Jardiance	Empagliflozin	45	12
Methadone Hcl	Methadone Hcl	45	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	11
Spironolactone	Spironolactone	43	12
Clopidogrel	Clopidogrel Bisulfate	42	suppressed
Carvedilol	Carvedilol	40	13
Estradiol	Estradiol	40	14
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Memantine Hcl	Memantine Hcl	39	suppressed
Clonazepam	Clonazepam	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Prednisone	Prednisone	35	24
Azelastine Hcl	Azelastine Hcl	34	15
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Pregabalin	Pregabalin	34	12
Mounjaro	Tirzepatide	33	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	18
Xarelto	Rivaroxaban	33	suppressed
Atenolol	Atenolol	31	suppressed
Lamotrigine	Lamotrigine	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	suppressed
Valacyclovir	Valacyclovir Hcl	29	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	28	suppressed
Econazole Nitrate	Econazole Nitrate	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Guanfacine Hcl	Guanfacine Hcl	26	suppressed
Sertraline Hcl	Sertraline Hcl	26	11
Tramadol Hcl	Tramadol Hcl	25	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Valsartan	Valsartan	23	suppressed
Dexlansoprazole Dr	Dexlansoprazole	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Klor-Con 10	Potassium Chloride	21	suppressed
Famotidine	Famotidine	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Alprazolam	Alprazolam	17	suppressed
Constulose	Lactulose	17	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	16
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Zafirlukast	Zafirlukast	16	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Furosemide	Furosemide	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Yuvafem	Estradiol	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Eplerenone	Eplerenone	13	suppressed
Estradiol (Twice Weekly)	Estradiol	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Relistor	Methylnaltrexone Bromide	13	suppressed
Repatha Syringe	Evolocumab	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error